Rheumatoid arthritis

Prevalence of Comorbidities and Poor Prognostic Factors Among Patients With Rheumatoid Arthritis in Bangladesh

J RheumatolPublished Cross-sectional study

Authors' conclusion

The prevalence of multimorbidity is high among patients with RA in Bangladesh, particularly early cardiovascular disease risk.

Study context

Population
Patients with rheumatoid arthritis (RA) at 2 tertiary care hospitals in Bangladesh
Participants
653 patients
Outcome
Prevalence of comorbidities
Methodological details2 tertiary care hospitals, logistic regression
  • 2 tertiary care hospitals
  • Logistic regression

Main finding

As reported in the abstract

≥ 1 comorbidity (prevalence)
Patients with ≥ 1 comorbidity
646 (98.9%)
Dyslipidemia
75.8%
Obesity
58.7%
Hypertension
42.7%
Type 2 diabetes mellitus
30.3%
Osteoporosis (OP)
15.6%

Observational data: associations, not effects.

Further findings

Mean

OutcomeOlder (≥ 45 years)YoungerP value
CCI survival index, older (≥ 45 years) vs younger patientsSignificantly lower in older patients68.7 (SD 26.7)93.3 (SD 6.7)P < 0.001

Factors associated with comorbidities: age ≥ 45 years

Coronary artery disease, OR
9.71 (1.91-178.00) (95% CI)
OP, OR
19.60 (5.96-121.00) (95% CI)
Infectious diseases, OR
1.60 (1.03-2.54) (95% CI)
  • Independently associated

Factors associated with comorbidities: female sex

Cardiovascular risk (lower), OR
0.27 (0.11-0.62) (95% CI)
OP, OR
3.55 (1.71-8.37) (95% CI)
Gastrointestinal (GI) disorders, OR
2.18 (1.37-3.56) (95% CI)

Infection risk with tsDMARD and bDMARD use

tsDMARD, OR
14.80
bDMARD, OR
4.11

GI comorbidities

High DAS28-CRP and ESR values linked to GI comorbidities

Original publication

Prevalence of Comorbidities and Poor Prognostic Factors Among Patients With Rheumatoid Arthritis in Bangladesh. J Rheumatol. Published 15 April 2026. doi:10.3899/jrheum.2025-1272

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.